Found 3 Vision Loss trials

A listing of Vision Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

ABC008-IBM-202

99 years and younger

All genders

A Long-Term Extension study for patients who have completed the double-blind treatment trial ABC008-IBM-201. The primary objective is to assess the long-term safety and tolerability of ulviprubart (ABC008) in subjects with Inclusion Body Myositis, as well as to assess long-term efficacy using a standardized weight-based dose (2.0 mg/kg) previously evaluated …

Learn More

CIELO WN43174

99 years and younger

All genders

A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER BASKET STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB IN PATIENTS WITH ANTIN-METHYL-D-ASPARTIC ACID RECEPTOR (NMDAR) OR ANTILEUCINE-RICH GLIOMA-INACTIVATED 1 (LGI1) ENCEPHALITIS

Learn More

UPCC 43424: A Phase 3, Randomized, Double-blind, Add-on Study Evaluating the Safety and Efficacy of Navtemadlin Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitini

99 years and younger

All genders

This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptimal response to ruxolitinib treatment alone.

Learn More